Why Can’t I Get Trulicity 3 mg at My Pharmacy?
If you’re struggling to fill your Trulicity 3 mg prescription, you’re not alone. This medication, vital for managing type 2 diabetes, is in short supply, especially at higher doses like 3 mg.
This article explains why can’t I get Trulicity 3 mg at my pharmacy, diving into the causes, impacts, and ways to navigate the shortage in 2025.
What Is Trulicity?
Trulicity, or dulaglutide, is a weekly injectable drug. It helps adults and children over 10 with type 2 diabetes control blood sugar. It also lowers heart disease risks for some patients.
Made by Eli Lilly, Trulicity is a GLP-1 receptor agonist. Its demand has surged, leading to shortages, particularly for the 3 mg dose. This leaves many wondering why can’t I get Trulicity 3 mg at my pharmacy.
When the Shortage Began
The Trulicity shortage started in June 2022. Eli Lilly reported an unexpected rise in demand. This overwhelmed their production capacity, causing stock shortages.
By 2025, the shortage persists, with higher doses like 3 mg and 4.5 mg hit hardest. The issue isn’t due to safety concerns but rather market and production challenges. The shortage is now expected to last until June 2026.
Why the 3 mg Dose Is Hard to Find
The 3 mg dose of Trulicity is in high demand. It’s effective for blood sugar control and moderate weight loss, making it popular. This demand outstrips supply, causing backorders.
Lower doses, like 0.75 mg and 1.5 mg, are more available. Pharmacies often run out of 3 mg first due to its widespread use. This explains why can’t I get Trulicity 3 mg at my pharmacy.
Surge in Demand
A major reason for the shortage is increased demand. Trulicity’s benefits for diabetes and its weight loss side effects have boosted its popularity. Many seek it for both medical and off-label uses.
Social media platforms, like TikTok, have amplified interest in GLP-1 drugs. This has led to a global spike in prescriptions. The demand surge has left pharmacies struggling to keep up.
Off-Label Use for Weight Loss
Trulicity isn’t FDA-approved for weight loss, but doctors prescribe it off-label. Its ability to reduce appetite and promote weight loss attracts non-diabetic users. This trend has skyrocketed demand.
Off-label use strains supplies, especially for higher doses like 3 mg. Diabetic patients often face delays as a result. This misuse contributes to why can’t I get Trulicity 3 mg at my pharmacy.
Ripple Effect from Other GLP-1 Shortages
The shortage of Ozempic, another GLP-1 drug, has worsened Trulicity’s availability. Ozempic’s shortage, starting in 2022, pushed patients to Trulicity as an alternative. This created a domino effect.
The 3 mg dose, being a higher strength, is particularly affected. Patients switching from Ozempic have increased pressure on Trulicity’s stock. This crossover demand is a key factor in the shortage.
Manufacturing and Supply Chain Issues
Eli Lilly faces challenges in producing enough Trulicity. The drug’s complex manufacturing process requires precise ingredients and time. Scaling up production isn’t quick or easy.
In early 2025, Eli Lilly reported manufacturing issues further delaying supply. Global supply chain disruptions, like raw material shortages, also play a role. These issues hit higher doses like 3 mg hardest.
How the Shortage Affects Patients
The Trulicity shortage disrupts diabetes management. Without the 3 mg dose, blood sugar levels may spike, raising risks of complications. Patients feel frustrated and anxious.
Many face weeks-long delays to fill prescriptions. Some must switch doses or medications, which can disrupt treatment. The shortage creates uncertainty for those relying on Trulicity.
Impact on Pharmacies and Doctors
Pharmacies struggle to stock Trulicity 3 mg. They often can’t predict when supplies will arrive. This leads to backorders and patient complaints.
Doctors must adjust treatment plans, sometimes prescribing lower doses or alternatives. This adds workload and stress. Pharmacists urge patients not to blame staff, as they don’t control supply.
Regional Differences in Availability
The shortage varies by region. In the U.S., the 3 mg and 4.5 mg doses are in limited supply, while 0.75 mg and 1.5 mg are more available. Europe, including Austria and Italy, also reports shortages.
In Australia and Canada, higher doses are scarce. Global demand makes it hard to distribute stock evenly. Local pharmacies may have different stock levels, so calling around helps.
Table: Trulicity Availability by Dose in 2025
| Dose (mg) | Availability | Notes |
|---|---|---|
| 0.75 | Generally available | Least affected by shortage |
| 1.5 | Mostly available | Occasional delays reported |
| 3.0 | Limited availability | High demand, frequent backorders |
| 4.5 | Severely limited | Hardest to find, ongoing shortages |
This table shows Trulicity’s availability by dose. The 3 mg dose faces significant shortages due to high demand and production limits.
Eli Lilly’s Response
Eli Lilly is working to address the shortage. They’ve invested $450 million to expand production, including a new facility in North Carolina. However, full improvements may not come until late 2026.
The company is releasing stock equitably to wholesalers. They’ve also prioritized existing patients over new ones. Despite these efforts, delays persist, especially for the 3 mg dose.
Regulatory Actions
The FDA and Australia’s TGA track Trulicity’s shortage. The FDA lists it on its Drug Shortage Database, updating availability. The TGA has approved temporary imports of U.S.-registered Trulicity.
These measures help, but they can’t fully resolve the issue. Regulators can’t force Eli Lilly to produce more. Patients should check shortage databases for updates.
Alternatives to Trulicity 3 mg
If Trulicity 3 mg isn’t available, doctors may suggest other GLP-1 drugs. Options include Ozempic, Victoza, or Mounjaro, though some face shortages too. Non-GLP-1 drugs, like metformin, are also options.
Switching requires medical supervision, as each drug has unique effects. Lower Trulicity doses, like 1.5 mg, may be an interim solution. Discuss alternatives with your doctor.
What Patients Can Do
Patients can take steps to manage the shortage. Calling multiple pharmacies to check stock is effective. Some pharmacies offer waitlists or restock alerts.
Patient assistance programs may provide access or discounts. Online or international pharmacies are options, but verify their legitimacy. Always consult your doctor before changing treatments.
Tips to Secure Trulicity 3 mg
Here are practical ways to find Trulicity during the shortage:
- Call several pharmacies to compare stock levels.
- Refill prescriptions early, ideally two weeks in advance.
- Ask your doctor about combining lower doses if available.
- Sign up for shortage alerts from the FDA or TGA.
These steps can improve your chances of getting Trulicity 3 mg. Persistence is key.
The Weight Loss Debate
The off-label use of Trulicity for weight loss has sparked controversy. Many argue diabetic patients should have priority. The 3 mg dose’s popularity for weight loss worsens its shortage.
Some call for stricter prescribing rules during shortages. Limiting off-label use could help diabetic patients access Trulicity. This issue remains unresolved but affects availability.
Looking Ahead
The Trulicity shortage, including the 3 mg dose, is expected to continue until June 2026. Eli Lilly’s production expansions may ease the crisis by late 2026. Until then, patients face challenges.
Better demand forecasting and supply chain improvements are needed. Staying proactive and informed helps patients navigate the shortage. Check official updates regularly for the latest news.
Staying Informed
Monitor Trulicity’s status through the FDA’s Drug Shortage Database. The TGA’s Medicine Shortage Reports Database offers updates for Australia. Eli Lilly’s website also posts supply announcements.
Pharmacies may share local stock updates. Signing up for email alerts from regulators ensures timely information. This helps you plan for refills and alternatives.
Why the Shortage Matters
The Trulicity shortage reveals flaws in drug supply chains. It shows how social trends, like weight loss fads, can disrupt access for medical needs. Diabetic patients suffer the most.
Addressing shortages requires global coordination. From manufacturing to distribution, every step must improve. The crisis highlights the need for stronger healthcare systems.
Summary
Why can’t I get Trulicity 3 mg at my pharmacy? A global shortage, driven by high demand, off-label weight loss use, and manufacturing issues, has limited supply since June 2022. The 3 mg dose is particularly scarce due to its popularity and the ripple effect from Ozempic’s shortage.
Eli Lilly is expanding production, but the shortage may last until June 2026. Patients can call pharmacies, explore alternatives, or use assistance programs, but medical guidance is essential. Staying informed through official sources helps manage this ongoing challenge.
FAQ
Why is Trulicity 3 mg so hard to find in 2025?
High demand, off-label weight loss use, and manufacturing issues have caused a shortage. The 3 mg dose is heavily sought after, leading to frequent backorders. The shortage is expected to last until June 2026.
What can I do if my pharmacy doesn’t have Trulicity 3 mg?
Call multiple pharmacies to check stock or join waitlists. Ask your doctor about lower doses or alternatives like Ozempic. Patient assistance programs or verified online pharmacies may also help.
Are other Trulicity doses affected by the shortage?
Yes, but the 3 mg and 4.5 mg doses are the most affected. The 0.75 mg and 1.5 mg doses are generally more available. Availability varies by pharmacy and region.
Will the Trulicity shortage end soon?
The shortage is expected to continue until June 2026. Eli Lilly is increasing production, but full relief may take time. Check the FDA or TGA for updates on supply status.